Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kjetil Weyde"'
Autor:
Thomas Helland, Bjørn Naume, Steinar Hustad, Ersilia Bifulco, Jan Terje Kvaløy, Anna Barbro Sætersdal, Marit Synnestvedt, Tone Hoel Lende, Bjørnar Gilje, Ingvil Mjaaland, Kjetil Weyde, Egil Støre Blix, Gro Wiedswang, Elin Borgen, Daniel Louis Hertz, Emiel Adrianus Maria Janssen, Gunnar Mellgren, Håvard Søiland
Publikováno v:
Molecular Oncology, Vol 15, Iss 4, Pp 957-967 (2021)
Low steady‐state levels of active tamoxifen metabolites have been associated with inferior treatment outcomes. In this retrospective analysis of 406 estrogen receptor‐positive breast cancer (BC) patients receiving adjuvant tamoxifen as initial tr
Externí odkaz:
https://doaj.org/article/162b341b32bb451fafcf55ad582ca776
Autor:
Steinar Hustad, Marit Synnestvedt, Jan Terje Kvaløy, Daniel L. Hertz, Anna Barbro Sætersdal, Gunnar Mellgren, Bjørnar Gilje, Elin Borgen, Ingvil Mjaaland, Håvard Søiland, Egil S. Blix, Emiel A. M. Janssen, Tone Hoel Lende, Kjetil Weyde, Gro Wiedswang, Bjørn Naume, Ersilia Bifulco, Thomas Helland
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 15, Iss 4, Pp 957-967 (2021)
Molecular Oncology, Vol 15, Iss 4, Pp 957-967 (2021)
Concentrations of active tamoxifen metabolites may be predictive of tamoxifen efficacy, and several therapeutic thresholds have been reported. This study of 406 ER+ breast cancer patients replicated an association between a previously reported active
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::243949774badb71683ce2b2d125a5556
https://pubmed.ncbi.nlm.nih.gov/33252186
https://pubmed.ncbi.nlm.nih.gov/33252186
Autor:
Gunnar Mellgren, Emiel A. M. Janssen, Bjørnar Gilje, Håvard Søiland, Tone Hoel Lende, Egil S. Blix, Daniel L. Hertz, Marit Synnestvedt, Kjetil Weyde, Anna Barbro Sætersdal, Jan Terje Kvaløy, Gro Wiedswang, Ersilia Bifulco, Bjørn Naume, Thomas Helland, Ingvil Mjaaland, Elin Borgen, Steinar Hustad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21f0711788396638577e84e0563a432e
https://doi.org/10.1002/1878-0261.12865/v2/response1
https://doi.org/10.1002/1878-0261.12865/v2/response1
Autor:
Christian Kersten, Christine Undseth, Eva Skovlund, Ingvil Mjaaland, Ingvild Vistad, Sophie D. Fosså, Marianne Grønlie Guren, Kjetil Weyde, Marte Grønlie Cameron, Rene van Helvoirt
Publikováno v:
Acta Oncologica. 55:1400-1407
Palliative pelvic radiotherapy (PPRT) is used to treat locally advanced rectal cancer (RC) although symptomatic effects and toxicities are poorly documented. Aims were to evaluate symptom severity, quality of life (QOL) and toxicity after PPRT.Fifty-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24b0993929e84b7247ba3d67404f5d1b
https://doi.org/10.1080/0284186x.2016.1191666
https://doi.org/10.1080/0284186x.2016.1191666
Autor:
Rene van Helvoirt, Christine Undseth, Kjetil Weyde, Ingvil Mjaaland, Eva Skovlund, Marte Grønlie Cameron, Marianne Grønlie Guren, Sophie D. Fosså, Christian Kersten, Ingvild Vistad
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 115(3)
Background and purpose Radiotherapy is used to palliate pelvic symptoms of castration resistant prostate cancer (CRPC). However, magnitude and time course of effects and toxicities are poorly documented. Study aims were to evaluate changes in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee351732b02e622159e158f854fa13bf
https://pubmed.ncbi.nlm.nih.gov/26091575
https://pubmed.ncbi.nlm.nih.gov/26091575
Autor:
Christian Kersten, Sophie D. Fosså, Marte Grønlie Cameron, Ingvil Mjaaland, Christine Undseth, R. Van Helvoirt, Kjetil Weyde, Ingvild Vistad, Eva Skovlund, Marianne Grønlie Guren
Publikováno v:
Radiotherapy and Oncology. 119:S366-S367
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e7c33a90da598273a1d46d3bb690f6
Autor:
Erik Wist, Elin Borgen, Anna Barbro Sætersdal, Christian Kersten, Ragnhild Sørum Falk, H. Sommer, Terje Risberg, Gro Wiedswang, Bjørn Naume, Ingvil Mjaaland, Maria Christine Rypdal, Cecilie Bendigtsen Schirmer, Kjetil Weyde, Lise Vindi, Marit Synnestvedt
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(34)
Purpose The presence of disseminated tumor cells (DTCs) in bone marrow (BM) predicts survival in early breast cancer. This study explores the use of DTCs for identification of patients insufficiently treated with adjuvant therapy so they can be offer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::515e8c7bc8cefa50326173828678ce88
https://pubmed.ncbi.nlm.nih.gov/25366688
https://pubmed.ncbi.nlm.nih.gov/25366688
Autor:
Christine Undseth, Eva Skovlund, Marianne Grønlie Guren, Marte Grønlie Cameron, R. Van Helvoirt, Sophie D. Fosså, Ingvil Mjaaland, Christian Kersten, Ingvild Vistad, Kjetil Weyde
Publikováno v:
Radiotherapy and Oncology. 115:S26-S27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f377ae02e2d5f43dfc2879461045a6f5
https://doi.org/10.1016/s0167-8140(15)40054-4
https://doi.org/10.1016/s0167-8140(15)40054-4
Autor:
Christian Kersten, Marit Synnestvedt, Lise Vindi, Cecilie Bendigtsen Schirmer, Ingvil Mjaaland, Kjetil Weyde, Elin Borgen, Terje Risberg, Gro Wiedswang, Bjørn Naume, Jahn M. Nesland, Erik Wist
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 616 (2012)
BMC Cancer
BMC Cancer
Background Presence of disseminated tumor cells (DTCs) in bone marrow (BM) after completion of systemic adjuvant treatment predicts reduced survival in breast cancer. The present study explores the use of DTCs to identify adjuvant insufficiently trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c13bf45d8cd660c70e8d7a18884b58db
https://hdl.handle.net/10037/25013
https://hdl.handle.net/10037/25013
Autor:
Kjetil Weyde, Arne E. Høiby, Dag Torfoss, B. Sandstad, Anne B. Jacobsen, Harald Holte, Stein Kvaløy, Kjell Grøttum, Jon Magnus Tangen, Kåre Bø, Grete F. Lauritzsen, Peter Meyer, Harald Olsen
Publikováno v:
The Journal of antimicrobial chemotherapy. 59(4)
Penicillin G with an aminoglycoside is the standard initial empirical treatment in febrile neutropenia in Norway. It has been argued that giving the aminoglycoside once daily to neutropenic patients with Gram-negative bacteraemia may be hazardous whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955c2fca4470774957d28d3f8a7123e4
https://pubmed.ncbi.nlm.nih.gov/17327294
https://pubmed.ncbi.nlm.nih.gov/17327294